ATRX IHC for 7 of the 28 cases demonstrated ambiguous staining with variability of labeling across tumor cells and internal control non-neoplastic cells, and were considered uninterpretable; these cases were excluded from further analysis. This evidence concerns the gene ATRX and neoplasm.